The use of Listeria monocytogenes as a DNA delivery vector for cancer gene therapy

Bioengineered Bugs

Volumn 1, Issue 4, 2010, Pages 284-287

  Tangney, Mark ^a   Van Pijkeren, Jan Peter ^a   Gahan, Cormac G M ^b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Bactofection; Cancer; Gene delivery; Listeria monocytogenes; Luminescence; Salmonella; Therapy; Tumor

Indexed keywords

BACTERIAL VECTOR; MOXIFLOXACIN; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; CANCER GENE THERAPY; CANCER IMMUNIZATION; CONTROLLED STUDY; DNA TRANSFER; GENE TARGETING; IMMUNOGENICITY; INTERNALIZATION; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PROMOTER REGION;

ANIMALS; CELL LINE, TUMOR; GENE THERAPY; GENETIC VECTORS; HUMANS; LISTERIA MONOCYTOGENES; MICE; MICE, NUDE; MICE, TRANSGENIC; NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

LISTERIA MONOCYTOGENES; MAMMALIA; MURINAE; SALMONELLA;

EID: 78650082236     PISSN: 19491018     EISSN: 19491026     Source Type: Journal    
DOI: 10.4161/bbug.1.4.12117     Document Type: Article

References (16)

1. Vassaux G, Nitcheu J, Jezzard S, Lemoine NR. Bacterial gene therapy strategies. J Pathol 2006; 208:290-8.
2. Tangney M, Gahan CG. Listeria monocytogenes as a Vector for Anti-Cancer Therapies. 2010; 10:46-55.
3. Hamon M, Bierne H, Cossart P. Listeria monocytogenes: a multifaceted model. Nat Rev Microbiol 2006; 4:423-34.
4. Dietrich G, Bubert A, Gentschev I, Sokolovic Z, Simm A, Catic A, et al. Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nat Biotechnol 1998; 16:181-5.
5. Schoen C, Kolb-Maurer A, Geginat G, Loffler D, Bergmann B, Stritzker J, et al. Bacterial delivery of functional messenger RNA to mammalian cells. Cell Microbiol 2005; 7:709-24.
6. van Pijkeren JP, Morrissey D, Monk IR, Cronin M, Rajendran S, O'Sullivan GC, et al. A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy. Hum Gene Ther 2010; 21:405-16.
7. Hof H. An update on the medical management of listeriosis. Expert Opin Pharmacother 2004; 5:1727-35
8. Grayo S, Join-Lambert O, Desroches MC, Le Monnier A. Comparison of the in vitro efficacies of moxifloxacin and amoxicillin against Listeria monocytogenes. Antimicrob Agents Chemother 2008; 52:1697-702.
9. Fujimori M, Amano J, Taniguchi S. The genus Bifidobacterium for cancer gene therapy. Curr Opin Drug Discov Devel 2002; 5:200-3.
10. Yu YA, Shabahang S, Timiryasova TM, Zhang Q, Beltz R, Gentschev I, et al. Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 2004; 22:313-20.
11. Wei MQ, Mengesha A, Good D, Anne J. Bacterial targeted tumour therapy-dawn of a new era. Cancer Lett 2008; 259:16-27.
12. Lecuit M, Vandormael-Pournin S, Lefort J, Huerre M, Gounon P, Dupuy C, et al. A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science 2001; 292:1722-5.
13. Wollert T, Pasche B, Rochon M, Deppenmeier S, van den Heuvel J, Gruber AD, et al. Extending the host range of Listeria monocytogenes by rational protein design. Cell 2007; 129:891-902.
14. Maciag PC, Radulovic S, Rothman J. The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix. Vaccine 2009; 27:3975-83.
15. Gahan CG, Collins JK. Vaccination of mice with attenuated mutants of Listeria monocytogenes: requirement for induction of macrophage la expression. Microb Pathog 1995; 18:417-22.
16. Stritzker J, Janda J, Schoen C, Taupp M, Pilgrim S, Gentschev I, et al. Growth, virulence and immunogenicity of Listeria monocytogenes aro mutants. Infect Immun 2004; 72:5622-9.